Gefen Megurim 2025: The Balance Sheet Swelled, But The Proof Year Still Runs Through Permits, Capital and Two Ashdod Projects

Getting To Know The Company

If you look only at Gefen Megurim's income statement, 2025 can easily read like a report from a tiny company that barely sells anything. Revenue was just ILS 78 thousand, all of it rental income, and gross profit was identical. Against that, selling and marketing expense plus G&A totaled ILS 7.76 million, and operating loss reached ILS 7.36 million. That is a very thin picture for anyone looking for a residential developer already living off apartment sales.

But that is no longer the full economic picture. By the end of 2025, Gefen was no longer a small platform with one investment apartment and a presentation deck. After the Abu transaction, it had become an urban-renewal platform with 33 projects across 9 cities, about 6,400 marketable units on the company's share according to the March 2026 presentation, and ILS 214.5 million of land inventory on the balance sheet. At the April 6, 2026 close of NIS 0.849 per share, the equity was trading around ILS 296.2 million.

What is working now is scale. The pipeline is larger, the geographic footprint is wider, and the company now has a few assets that are much closer to permits and launches. What is not yet working is conversion. The company ended the year with negative cash from operations of ILS 17.3 million, just ILS 6.5 million of cash on hand, and 12 month working capital that was negative by ILS 3.9 million after adjusting for the operating cycle. The story has therefore moved from "does it even have a business" to "does it have enough capital, project finance and execution discipline to turn that business into cash."

The active bottleneck is not some abstract question about housing demand. It is much more concrete: permits, project finance, equity funding, and the ability to turn two large Ashdod projects, Zabotinsky and Pladot, from inventory and valuation math into actual launches. Without that, the balance-sheet jump will remain mostly a book value event.

Four non-obvious points stand out immediately:

• First finding: the jump in equity came from a share-swap transaction and purchase-price allocation, not from operating improvement. Attributable equity rose from ILS 45.2 million to ILS 121.9 million while the company still posted a full-year loss.
• Second finding: management had to publish a two year cash forecast because 12 month working capital was negative and operating cash flow remained negative.
• Third finding: Zabotinsky and Pladot alone account for ILS 286.4 million, about 63% of the gross profit the company attributes to its share in the advanced 2026 and 2027 project layer.
• Fourth finding: the institutional credit line of ILS 20 million improves breathing room, but it is tied to Zabotinsky and can tighten if that project does not reach formal project finance on time.

That chart is the core reading. What grew was the balance sheet, the land inventory and the deal-related debt. What still did not grow was the company's ability to show core revenue and profitability.

Events And Triggers

The Abu transaction changed the scale, but it also imported a large set of assumptions

On December 30, 2025, Gefen completed the acquisition of I.Z.Y Abu 2025 through the issuance of 107,458,221 shares, equal to 33.0049% of its equity. This was the move that changed the company overnight. It absorbed a much wider urban-renewal package, especially around Ashdod, and land inventory rose to ILS 214.5 million.

But it matters what exactly came in. The purchase-price allocation sets total business combination cost at ILS 97.0 million. Of that, ILS 110.8 million was allocated to excess value in the project backlog, against a tax reserve of ILS 25.5 million, ILS 1.8 million of excess value in the shareholder loan, and ILS 6.5 million of goodwill. Put differently, a meaningful part of the balance-sheet jump came from valuation of future projects, not from signed sales or cash already on hand.

That is not a technical footnote. In the PPA appendix, Pladot and Zabotinsky alone account for ILS 71.2 million, about 64% of the excess value attributed to the acquired backlog. The excess values assigned to Neot Sapir, Hativat Carmeli, Uriya A and Harei Golan already rest on earlier planning stages, and the valuers use discount rates between 11.5% and 14.5% with certainty factors between 95% and 50%. In other words, the company imported value, but that value still runs through a heavy layer of planning and timing assumptions.

That chart is why the Gefen read has to begin with Ashdod. Not all pipeline is equal, and not every stage of the pipeline carries the same economic weight.

The new capital helps, but it also signals that the company is still building its funding layer

The second event that points in the same direction is the Nati Gilboa transaction. Under the amended agreement, Gilboa paid ILS 14.195 million in the first stage for 22.18 million shares plus options, and is supposed to buy another 15.18 million shares for ILS 9.716 million over 36 months, with 7.2% interest after the first 12 months. The first tranche was completed on March 12, 2026.

For the company, this is positive in two ways. It is real cash arriving after the balance-sheet date, and it is also a signal that a private investor is willing to put personal capital behind the story. But that second signal matters almost as much as the cash: the existing balance sheet was still not deep enough for the pipeline the company had just imported.

The same message comes through even more clearly in the non-binding memorandum with Leumi Partners signed on January 4, 2026. On paper, that framework is much larger than the current company: a 20% equity placement at NIS 0.85 per share, an ILS 100 million convertible loan, and potential loans of ILS 150 million to ILS 450 million into a dedicated subsidiary. As long as it remains non-binding, it cannot sit at the center of the thesis. But as a signal, it is very clear: Gefen is trying to build a capital platform far larger than the one with which it exited 2025.

The operating story is becoming more and more of an Ashdod story

In the March 2026 presentation, the company highlights four key operational events in the advanced layer: Zabotinsky in Ashdod, Pladot in Ashdod, Ha'atzmaut in Yavne, and Alkalay in Petah Tikva. The two Ashdod projects, Zabotinsky and Pladot, are the largest by far in terms of expected gross profit on the company's share.

Alongside that, new threads were added after the balance-sheet date. A February 26, 2026 report describes a promotion agreement with a third-party developer on an Ashdod site of 2,448 square meters, where the current detailed plan allows only 35 units and the goal is to promote a new plan reflecting a 28 floor policy or more. The presentation also flags HaRishonim in Ashdod, with about 234 units expected for marketing and the start of planning, and Rogozin 15-17 in Ashdod, with about 192 units expected for marketing and a final agreement form already reached.

This does not mean all of the company's value sits in one city. It does mean that the value nearest to monetization runs through Ashdod much more heavily than a headline such as "33 projects in 9 cities" first suggests.

Efficiency, Profitability And Competition

The income statement still barely measures the core business

With Gefen, there is still no meaningful price-volume-mix discussion in the classic sense of a developer already delivering apartments at scale. In 2025, revenue came from rental income only, ILS 78 thousand, and gross profit was identical. Selling and marketing expense stood at ILS 190 thousand, G&A at ILS 7.57 million, and operating loss widened to ILS 7.36 million.

That does not mean there is no business here. It means the 2025 filing still tells the story through the balance sheet, the project tables and the post-balance-sheet events rather than through the revenue line. Gefen is currently more of an organizing, financing and project-advancement platform than a delivery machine. Even the human-capital footprint says as much: the company had only 6 employees at the report date, including workers not formally employed in standard employee relationships. That is a very thin operating shell relative to the pipeline it is now presenting.

The quality of the pipeline matters more than the size of the pipeline

In the presentation, the company lists advanced projects with the required majority that are expected to move to launches or permits in 2026 and 2027. On the company's share, that layer represents expected revenue of ILS 2.527 billion and expected gross profit of ILS 453.7 million. That is a very large number relative to the current size of the company, and it is easy to get carried away by it.

But the distribution of that number shows that the near-term layer is not truly diversified. Zabotinsky contributes ILS 146.1 million, Pladot ILS 140.4 million, Alkalay ILS 61.1 million and Ha'atzmaut in Yavne ILS 38.9 million. Those four projects together represent about 85% of the gross profit the company assigns to the advanced layer. That is no longer a story about a broad backlog. It is a story about a handful of projects that all need to pass through the same chain: final signature threshold, permit, project finance, contractor and launch.

That is exactly where backlog has to be separated from executable backlog. The company has clearly enlarged the inventory base and the number of sites, but the near-term read is concentrated in a few large projects, especially two in Ashdod.

Even the auditors are signaling that the balance sheet needs a cautious read

The two key audit matters were capitalization of costs into inventory and the accounting treatment of the business combination. That is not accidental. In Gefen's case, the quality of the balance sheet depends on two judgment-heavy areas: whether it remains appropriate to keep capitalizing project costs for sites that are not yet in execution, and how to measure the economic uplift imported from a related-party acquisition.

That does not mean the numbers are wrong. It means the decisive question for Gefen in 2025 is not whether it has more inventory or more equity on paper, but how much of those layers will actually mature into permits, project finance and launches. For a developer already selling apartments, you debate gross margin. For Gefen at the end of 2025, you first have to debate the maturity quality of the balance sheet.

Cash Flow, Debt And Capital Structure

Cash Flow

I am using an all-in cash flexibility lens here, because that is the real question for Gefen right now: how much room remains after actual cash uses, not how much theoretical value has been booked into the pipeline.

In 2025, cash declined from ILS 14.469 million to ILS 6.473 million. Cash from operations was negative by ILS 17.289 million. Investing cash flow was positive by ILS 2.199 million, mainly because of an asset sale, and financing cash flow was positive by ILS 7.094 million, mainly because the company drew short-term credit. Put differently, the company ended the year with a thin cash balance even after already pulling in short-term funding.

The reason is not unusual for an urban-renewal developer, but it is still heavy. In the cash-flow reconciliation, the increase in building inventory and land inventory consumed ILS 14.05 million, while the increase in payables, accruals and related parties added only ILS 1.37 million. This is exactly the kind of environment in which the company has to spend cash before it can show core revenue.

One more nuance matters. The company still had positive working capital of ILS 9.188 million in the consolidated balance sheet, but once it adjusts that number for a 12 month horizon, working capital turns negative by ILS 3.864 million. That is why the board had to publish a forecast cash flow statement. There is no immediate insolvency read in the filing, but there is also no cushion that allows investors to be casual about timing.

Debt And Covenants

The debt layer is complicated, but not immediately tight. The convertible bond stands at ILS 46.160 million, carries a fixed 7% rate, and matures in a single payment on September 30, 2028. The indenture requires minimum consolidated equity of ILS 20 million and adds 0.25% to the coupon if consolidated equity falls below ILS 25 million. Against attributable equity of ILS 121.9 million, there is a wide buffer here.

The more interesting debt sits around the bond:

The most important line in that table is not the facility size but the dependence of the institutional line on Zabotinsky. If no project-finance agreement is signed within nine months of the credit agreement, the lender may demand repayment or cancel the line. So the facility improves flexibility, but only as long as Zabotinsky progresses.

The 2026 forecast is first and foremost a funding plan

Management's 2026 cash forecast is built on total sources of ILS 144.5 million against uses of ILS 55.8 million, leaving projected year-end cash of ILS 95.1 million. That sounds reassuring until the source mix is broken down.

The main sources are ILS 14.2 million from the Nati Gilboa transaction, ILS 20 million from the institutional line, ILS 80 million from a new bond series, and ILS 20.274 million from credit meant to fund equity needs in projects that reach permits and closed bank accompaniment. In other words, the 2026 plan depends far less on self-generated cash and far more on the ability to raise capital and close project finance.

That is the heart of the financial story. 2026 is not a year in which the existing business is expected to fund itself. It is a year in which the company has to prove that it can connect the larger pipeline to a sufficiently deep capital structure.

Forecasts And Forward View

Four points have to stay front of mind when reading the next year:

• First finding: the company does not first need to prove demand. It needs to prove closure. Much of the advanced layer already has high signature rates. The test is moving to permits, project finance and launch.
• Second finding: value has already been created partly on the balance sheet, but it is not yet accessible to common shareholders. It still has to pass through partners, equity requirements, debt and timing.
• Third finding: Zabotinsky is both a value engine and a funding asset. Any delay there hurts two layers at once.
• Fourth finding: the read can change quickly in either direction because the current financial statements contain almost no recurring operating earnings that can absorb execution mistakes.

What actually has to happen in 2026 and into 2027

Zabotinsky is the first checkpoint. In the annual project table, signatures stand at 95%, launch is planned for September 2026, construction start for December 2026 and first stage completion for December 2029. But at the prerequisite level, the company itself is explicit about what is still missing: signatures must reach 100%, a building permit must be obtained, and project finance and a contractor agreement must be signed. That is the real bridge from book value to operating value.

Pladot is the second checkpoint. Here too the company has 97% signatures, here too launch is aimed at October 2026, and here too it still needs 100% signatures, a permit, project finance and a contractor. The difference is ownership: Gefen holds only 35% of the rights, while the Tedar group holds 65%. So even if Pladot progresses smoothly, a large part of the economics stays with the partner.

Beyond those two anchors, the company is leaning on additional support points. In HaPalmach 47 in Tel Aviv, the cash forecast assumes a full building permit and release of ILS 2.02 million of equity. Management also expects other projects in the advanced layer to move toward permits or launches in 2026 and 2027. But those projects by themselves will not be enough if the two large Ashdod sites slip.

This looks like a proof year in planning and funding, not a harvest year

The right way to read the next year is as a proof year. Not because the company lacks backlog, but because it is still at the stage where it has to prove that a much wider planning book can become funded execution.

That comes through in how the company presents itself. On one hand, it already shows about ILS 454 million of expected gross profit and about ILS 2.527 billion of expected revenue on the company's share from projects expected to move to launch or execution over the next 24 months. On the other hand, the 2025 consolidated financial statements still contain almost no evidence that this activity has started flowing through the revenue line. So 2026 is not a harvest year. It is a transition year that has to prove the pipeline can move.

Created value is still far from accessible value

This matters especially at Gefen because a large part of the value has already been "created" in accounting terms. The Abu transaction expanded inventory, equity, minority interests and goodwill. The presentation provides very large revenue and gross-profit estimates. But common shareholders do not benefit from excess value, gross-profit tables or certainty factors. They benefit only once projects reach launch, project finance, execution, recognition and cash.

That gap is obvious even inside the projects themselves. In Pladot, for example, the annual project table shows expected gross profit of ILS 401.0 million on a 100% basis, while the presentation translates the company's share into only ILS 140.4 million. In Zabotinsky, by contrast, the full ILS 146.1 million of expected gross profit belongs to the company because the ownership is full. That is why it is not enough to talk about "backlog." You always have to ask at which layer of rights the number sits.

What may change the market reading in the short and medium term

There is a wide gap between what the market sees in the current filing and what it may see if a few checkpoints are cleared successfully. If Zabotinsky and Pladot obtain permits, close project finance and move to launch at roughly the pace presented by management, the market could shift from reading Gefen as a listed shell with a deck to reading it as an urban-renewal platform with a first monetization lane. In that case, the balance sheet and the presentation would begin to connect to real operating activity.

On the other hand, if one of those axes stalls, especially Zabotinsky, the read could worsen quickly. The reason is simple: there is no recurring earnings engine today that can carry the filing while the pipeline is delayed. Every deviation in timing or funding therefore hits the thesis directly.

Risks

Operational and geographic concentration

The headline of 33 projects in 9 cities looks diversified. The near-term profitability layer is far less so. Zabotinsky and Pladot are the center of gravity of the advanced layer, and both sit in Ashdod. The post-balance-sheet threads, HaRishonim, Rogozin and the new promotion agreement, add even more weight to the same city. If planning pace or municipal context in Ashdod slows, too large a part of the near-term story slows with it.

Funding risk, dilution risk and capital-markets dependence

The company itself says 2026 depends on a new bond raise, on credit facilities and on capital entering alongside permits. This is not a side note. It is the financial thesis. Even if the existing debt is not close to covenant pressure, the company still needs another layer of capital to move the current pipeline into execution. That creates sensitivity to the debt market, to the equity price, and to the structure of project-finance terms.

Accounting-quality risk

The auditors highlighted two areas: cost capitalization into inventory and business-combination accounting. Those are exactly the places where a company can legitimately show a stronger picture on paper than in cash. As projects mature, that risk should decline. As long as a large part of the balance sheet still rests on relatively early stages, it has to stay on the table.

Governance and related-party complexity

The Abu transaction is a related-party transaction. The Gilboa transaction adds capital and management alignment, but it also adds a more complex governance layer, including a voting arrangement that activates if he reaches a specified ownership level. In addition, the non-bank loan taken in September 2025 is backed by the controlling shareholder's personal guarantee. This does not point to an immediate problem, but it does mean the company still relies on a capital and control structure that is less clean than a mature developer would ideally want.

Legal and sector risk

Beyond the standard sector risks, construction-input inflation, labor availability, interest rates and planning approvals, the company is also involved in litigation against InterCure of about ILS 8.2 million, alongside a ILS 1.1 million counterclaim, with legal advisers saying the outcome cannot yet be assessed. This is not the core issue, but in a small company even side threads like this deserve monitoring.

Short Interest Read

Short data does not tell an extreme story here, but it does add a useful layer. As of March 27, 2026, short float stood at 0.61%, below the sector average of 0.83%. On first read, that looks negligible. The issue is that SIR still stood at 4.22 days to cover, above the sector average of 2.927.

The practical translation is simple: there is no aggressive short against the equity base, but there is also no deep trading screen that fully erases skepticism. That fits a stock in which the bearish view has cooled, while actionability remains limited.

What matters more is the direction. At the start of January, short float stood at 1.04% and SIR reached 9.79. By the end of March, both had clearly declined. That suggests part of the market stopped betting on immediate deterioration, likely after the Gilboa capital injection and the improvement in credit facilities. Still, SIR remains relatively high, which is a reminder that the market has not fully bought the thesis.

Conclusions

Gefen Megurim went through a fast shape shift in 2025. It exited the year as a much broader urban-renewal platform, with a larger balance sheet, a new CEO and the first post-balance-sheet equity injection from management. But at the end of the cycle, it is still not a developer proving residential economics through reported results. It is a company asking the market to believe that it can turn pipeline, PPA and bridge funding into real execution.

Current thesis: Gefen currently reads as an expanding pipeline company with two relatively near-term value anchors in Ashdod, not as a proven execution company.

What changed versus the pre-deal version of Gefen is not the income statement but the structure of the story. The company is no longer judged on whether it has enough projects. It is judged on whether it has enough capital, project finance and execution discipline to move the projects already imported into the balance sheet.

The strongest counter-thesis is that the market is still underestimating the scale jump. If the company closes permits, project finance and another capital layer on time, the gap between the thin 2025 statements and the much broader pipeline could close relatively quickly.

What can change the market reading in the short to medium term is not another presentation but a sequence of three proofs: permits, project finance and capital raising. If those arrive, the balance sheet will start to look like preparation for execution. If they are delayed, the same balance sheet will look like value still trapped on paper.

Why does this matter? Because in an early-stage urban-renewal developer, the critical question is not only how many projects exist, but who funds the route until they become launched, financed and cash-generating, and how much of that value remains accessible to common shareholders after partners, debt and timing.

Over the next two to four quarters, the thesis strengthens if Zabotinsky and Pladot move into permits, project finance and actual launches, and if the company closes additional funding without overstraining the capital structure. It weakens if project finance is delayed, if the expected new bond raise does not happen, or if it becomes clear that the balance-sheet jump is still far ahead of real monetization.